{"title":"Treatments","description":"\u003cp\u003eBaseline therapies are designed around one principle: measure first, then act with precision. Explore treatment options across metabolic health, longevity, recovery, performance, skin health, and cognitive energy — each supported by education, biomarker context, and provider-guided evaluation when prescription therapy is appropriate.\u003c\/p\u003e","products":[{"product_id":"compounded-semaglutide","title":"Compounded Semaglutide","description":"\u003cp\u003e\u003cstrong\u003eGLP-1 receptor agonist supporting insulin sensitivity and weight management.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eSemaglutide is a GLP-1 receptor agonist. The compounded formulation is prepared by FDA-registered, state-licensed compounding pharmacies. It is not FDA-approved and has not undergone FDA premarket review for safety, efficacy, or quality. Brand-name semaglutide products (Ozempic, Wegovy) are FDA-approved; the compounded formulation is a distinct, non-approved product.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eGLP-1 receptors are present in the pancreas, GI tract, and central nervous system. Activation modulates insulin secretion in a glucose-dependent manner, slows gastric emptying, and affects appetite signaling pathways. Research on brand-name formulations has documented cardiovascular and metabolic effects. Whether compounded formulations produce equivalent results has not been independently established.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eContraindicated: personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).\u003c\/li\u003e\n\u003cli\u003eAnimal studies showed potential thyroid C-cell tumor risk. Human relevance not confirmed.\u003c\/li\u003e\n\u003cli\u003eCommon: nausea, reduced appetite, GI symptoms during dose titration.\u003c\/li\u003e\n\u003cli\u003ePrescription required following provider evaluation.\u003c\/li\u003e\n\u003cli\u003eHSA\/FSA eligible when prescribed for a qualifying medical condition.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eNausea — most common, particularly during dose titration. Typically decreases over 4–8 weeks.\u003c\/li\u003e\n\u003cli\u003eVomiting, diarrhea, or constipation — GI effects are dose-dependent and usually improve.\u003c\/li\u003e\n\u003cli\u003eReduced appetite — an expected pharmacological effect.\u003c\/li\u003e\n\u003cli\u003eInjection site reactions: redness, bruising, or itching at the injection site.\u003c\/li\u003e\n\u003cli\u003eRare: pancreatitis. Seek immediate medical attention for severe, persistent abdominal pain.\u003c\/li\u003e\n\u003cli\u003eRare: gallbladder disease — risk increases with rapid weight loss.\u003c\/li\u003e\n\u003cli\u003eContraindicated in personal or family history of MTC or MEN2.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933497700504,"sku":"BL-COMPOUNDED-SEMAGLUTIDE","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/Semaglutide_Glycine_compounded_solution_vial.png?v=1777263943"},{"product_id":"compounded-tirzepatide","title":"Compounded Tirzepatide","description":"\u003cp\u003e\u003cstrong\u003eDual GIP\/GLP-1 receptor agonist for metabolic support.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eTirzepatide is a dual GIP and GLP-1 receptor agonist. The compounded formulation is not FDA-approved. Brand-name tirzepatide (Mounjaro, Zepbound) is FDA-approved. Whether the compounded formulation produces equivalent results to approved products has not been independently studied.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eGIP and GLP-1 receptors together influence insulin secretion, glucagon suppression, gastric motility, and appetite regulation through complementary pathways. Clinical trial data on brand-name tirzepatide showed meaningful effects on body weight and metabolic markers in the studied populations.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eSame MTC\/MEN2 contraindications as all GLP-1 class agents.\u003c\/li\u003e\n\u003cli\u003eSide effect profile similar to GLP-1 monotherapy.\u003c\/li\u003e\n\u003cli\u003ePrescription required. HSA\/FSA eligible when prescribed for a qualifying condition.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eNausea and GI effects (vomiting, diarrhea, constipation) — similar profile to GLP-1 monotherapy.\u003c\/li\u003e\n\u003cli\u003eInjection site reactions.\u003c\/li\u003e\n\u003cli\u003eRare: pancreatitis risk — same monitoring applies as GLP-1 class agents.\u003c\/li\u003e\n\u003cli\u003eContraindicated in personal or family history of MTC or MEN2.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933497766040,"sku":"BL-COMPOUNDED-TIRZEPATIDE","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/tirz.png?v=1777263944"},{"product_id":"compounded-retatrutide","title":"Compounded Retatrutide","description":"\u003cp\u003e\u003cstrong\u003eTriple-receptor agonist — investigational. Phase 2 data only.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eRetatrutide is an investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors. It has completed Phase 2 trials but is not FDA-approved in any form. Compounded retatrutide is not the same as any approved medication. Phase 2 NEJM data showed notable effects on body weight in the studied population. Phase 3 data is not yet available.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eAdding glucagon receptor agonism introduces additional effects on energy expenditure and hepatic glucose output. Long-term safety profile has not been established.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eAvailable only where prior GLP-1 or dual GIP\/GLP-1 therapy has been clinically insufficient.\u003c\/li\u003e\n\u003cli\u003eNot FDA-approved in any form. Phase 3 trials ongoing as of this writing.\u003c\/li\u003e\n\u003cli\u003eMTC\/MEN2 contraindication applies. Requires provider evaluation.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eGI effects (nausea, reduced appetite, diarrhea) — expected given triple-receptor mechanism.\u003c\/li\u003e\n\u003cli\u003eInjection site reactions.\u003c\/li\u003e\n\u003cli\u003eLong-term safety profile not yet established — Phase 3 data is not yet available.\u003c\/li\u003e\n\u003cli\u003eSame MTC\/MEN2 contraindication applies as other GLP-1 class agents.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933497831576,"sku":"BL-COMPOUNDED-RETATRUTIDE","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/Retatrutide_compounded_solution_vial.png?v=1777263943"},{"product_id":"mic-b12-injection","title":"MIC-B12 Injection","description":"\u003cp\u003e\u003cstrong\u003eLipotropic support for hepatic fat metabolism and energy production.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eMIC-B12 is a compound injection containing Methionine, Inositol, Choline, and Vitamin B12. These nutrients are each involved in hepatic fat metabolism, methylation pathways, and cellular energy production. This is a supportive compound — not a weight loss medication.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eMethionine is a methyl donor involved in fat transport. Inositol plays a role in insulin signaling and lipid metabolism. Choline is essential for phospholipid synthesis. B12 supports methylation and neurological function.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eUsed as a complement to GLP-1 therapy — not as a primary metabolic intervention.\u003c\/li\u003e\n\u003cli\u003eNot a substitute for diet, exercise, or evidence-based metabolic therapies.\u003c\/li\u003e\n\u003cli\u003eIndividual response varies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site reactions — standard for any SubQ injection.\u003c\/li\u003e\n\u003cli\u003eRare: allergic response to any component. Notify provider immediately if rash or unusual symptoms develop.\u003c\/li\u003e\n\u003cli\u003eMild flushing shortly after injection reported by some individuals.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933497962648,"sku":"BL-MIC-B12-INJECTION","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/MIC_B12.png?v=1777263943"},{"product_id":"nad-subcutaneous-injection","title":"NAD+ Subcutaneous Injection","description":"\u003cp\u003e\u003cstrong\u003eSystemic NAD+ replenishment via subcutaneous injection.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eNAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy metabolism and DNA repair signaling. Measured NAD+ levels in human tissue decline with age. SubQ injection delivers NAD+ systemically, bypassing GI degradation that limits oral forms. The clinical significance of NAD+ supplementation in otherwise healthy adults has not been fully established in large randomized controlled trials.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eNAD+ functions as an electron carrier in metabolic pathways and as a substrate for PARPs (involved in DNA repair) and sirtuins. Preclinical data is extensive; human clinical data is more limited and ongoing.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site reactions (warmth, mild flushing) are common and typically transient.\u003c\/li\u003e\n\u003cli\u003eIndividual response varies. Effects are not guaranteed.\u003c\/li\u003e\n\u003cli\u003eRequires provider evaluation and prescription.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site warmth, flushing, or mild discomfort — common and typically resolve within minutes.\u003c\/li\u003e\n\u003cli\u003eMild fatigue or headache reported by some users, particularly with higher doses early in protocol.\u003c\/li\u003e\n\u003cli\u003eNausea occasionally reported. Starting at lower doses and titrating typically reduces this.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498028184,"sku":"BL-NAD-SUBCUTANEOUS-INJECTION","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/NAD_compounded_solution_vial_close-up.png?v=1777263943"},{"product_id":"nad-intranasal-spray","title":"NAD+ Intranasal Spray","description":"\u003cp\u003e\u003cstrong\u003eNAD+ delivered via the nasal pathway for CNS applications.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eIntranasal delivery of NAD+ utilizes the olfactory and trigeminal pathways to reach the CNS more directly than systemic routes. The pharmacokinetics of intranasal NAD+ in humans are not fully characterized. Clinical evidence is more limited than for systemic delivery.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eThe nasal mucosa provides access that partially bypasses the blood-brain barrier, potentially allowing higher CNS delivery relative to systemic administration. NAD+ supports neuronal energy metabolism.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eNasal irritation is possible. Use as directed.\u003c\/li\u003e\n\u003cli\u003eNot a treatment for neurological conditions or cognitive disorders.\u003c\/li\u003e\n\u003cli\u003eIndividual response varies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eNasal irritation, mild burning sensation, or transient congestion — most commonly reported effect.\u003c\/li\u003e\n\u003cli\u003eHeadache reported by some users following use.\u003c\/li\u003e\n\u003cli\u003eAvoid contact with eyes. Store away from heat and light as directed.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498126488,"sku":"BL-NAD-INTRANASAL-SPRAY","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/NAD_compounded_solution_nasal_spray.png?v=1777263943"},{"product_id":"ghk-cu-injectable","title":"GHK-Cu Injectable","description":"\u003cp\u003e\u003cstrong\u003eCopper-binding tripeptide involved in tissue remodeling pathways.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eGHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found in human plasma that declines with age. Research — primarily in vitro and animal studies — suggests involvement in tissue remodeling, wound healing, and gene expression regulation. Human clinical data is more limited. This is a compounded peptide therapy, not an FDA-approved medication.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eGHK-Cu has been studied in the context of collagen synthesis, anti-inflammatory signaling, and tissue repair. It is thought to act by modulating gene expression. The breadth of genes potentially influenced in vitro does not necessarily predict equivalent systemic effects in humans at clinical doses.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjectable form provides systemic delivery.\u003c\/li\u003e\n\u003cli\u003eInjection site reactions are possible.\u003c\/li\u003e\n\u003cli\u003eNo specific anti-aging or cosmetic outcome is guaranteed. Results are individual.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site redness or mild discomfort — typical for SubQ injections.\u003c\/li\u003e\n\u003cli\u003eMetallic taste reported by some users due to the copper component.\u003c\/li\u003e\n\u003cli\u003eNo serious adverse events prominently reported in available literature at standard doses.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498224792,"sku":"BL-GHK-CU-INJECTABLE","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/GHK_CU.png?v=1777263944"},{"product_id":"ghk-cu-topical-cream","title":"GHK-Cu Topical Cream","description":"\u003cp\u003e\u003cstrong\u003eCompounded GHK-Cu at therapeutic concentrations for dermal application.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eTopical GHK-Cu is compounded at concentrations above those typically found in cosmetic products. Dermal penetration of copper peptides varies by formulation, vehicle, and individual skin characteristics. Research at the cellular level suggests involvement in collagen and elastin pathway activation. Clinical evidence in humans is more limited.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eTopical application targets the dermis. GHK-Cu is proposed to support fibroblast activity and reduce localized inflammation at the application site.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eConsistent application over weeks to months is required to assess response.\u003c\/li\u003e\n\u003cli\u003eNot a substitute for medical treatment of skin conditions.\u003c\/li\u003e\n\u003cli\u003eIndividual response varies significantly.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eMild skin redness or irritation at the application site, particularly in sensitive skin types.\u003c\/li\u003e\n\u003cli\u003eTemporary skin tightness following application.\u003c\/li\u003e\n\u003cli\u003eDiscontinue use and contact your provider if significant irritation, rash, or allergic response develops.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498323096,"sku":"BL-GHK-CU-TOPICAL-CREAM","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/GHK-CU_topical_cream_tube.png?v=1777263943"},{"product_id":"bpc-157","title":"BPC-157","description":"\u003cp\u003e\u003cstrong\u003eSynthetic peptide with a preclinical research base in tissue repair.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eBPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a sequence found in human gastric juice. It has a substantial body of preclinical research — primarily rodent studies — on tissue repair, gastrointestinal healing, and anti-inflammatory signaling. Human clinical trial data is limited. It is not FDA-approved and is used as an investigational compounded peptide.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003ePreclinical data suggests involvement in growth factor upregulation, angiogenesis, and modulation of inflammatory pathways. Mechanisms in humans at therapeutic doses have not been fully characterized.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eLimited human clinical data. Prescribed based on preclinical evidence and clinical judgment.\u003c\/li\u003e\n\u003cli\u003eNot a treatment for any diagnosed condition.\u003c\/li\u003e\n\u003cli\u003eRequires provider evaluation. Individual response varies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site reactions (mild redness, discomfort) — most commonly reported effect.\u003c\/li\u003e\n\u003cli\u003eMild nausea reported by some users, particularly early in the protocol.\u003c\/li\u003e\n\u003cli\u003eLong-term human safety data is limited. No serious adverse events have been prominently documented in available preclinical and observational literature.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498388632,"sku":"BL-BPC-157","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/BPC_157.png?v=1777263944"},{"product_id":"tb-500","title":"TB-500 (Thymosin Beta-4 Analog)","description":"\u003cp\u003e\u003cstrong\u003eSynthetic Thymosin Beta-4 analog — preclinical data, very limited human data.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eTB-500 is a synthetic analog of Thymosin Beta-4, an endogenous peptide involved in actin regulation and cellular migration. Preclinical research suggests involvement in tissue repair, particularly in areas with limited vascularity. Human clinical data is very limited. This is a compounded investigational peptide, not an FDA-approved medication.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eThymosin Beta-4 is involved in actin sequestration and cell migration. TB-500 is proposed to support tissue repair by promoting cell migration to injury sites. These effects have been studied primarily in animal models.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eVery limited human clinical data.\u003c\/li\u003e\n\u003cli\u003eNot a treatment for diagnosed injuries or conditions.\u003c\/li\u003e\n\u003cli\u003eRequires provider evaluation. Results are not guaranteed.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site reactions (mild redness, swelling).\u003c\/li\u003e\n\u003cli\u003eMild fatigue or flu-like feeling reported by some users in early use.\u003c\/li\u003e\n\u003cli\u003eLong-term effects in humans are not well characterized — very limited human safety data exists.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498486936,"sku":"BL-TB-500-THYMOSIN-BETA-4-ANALOG","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/TB500.png?v=1777263943"},{"product_id":"wolverine-blend","title":"Wolverine Blend (BPC-157 + TB-500)","description":"\u003cp\u003e\u003cstrong\u003eCombined BPC-157 and TB-500 for tissue repair support.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eThe Wolverine Blend combines BPC-157 and TB-500 in a single formulation. The rationale is that each compound is proposed to support tissue repair through different mechanisms. Combination data in humans is not available. All preclinical caveats for both individual compounds apply.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eSee individual BPC-157 and TB-500 descriptions. Additive or synergistic effects in humans have not been studied in controlled trials.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003ePrescribed when a provider determines both compounds are appropriate.\u003c\/li\u003e\n\u003cli\u003eAll preclinical limitations of both compounds apply.\u003c\/li\u003e\n\u003cli\u003eRequires provider evaluation.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site reactions — expected with any SubQ injection protocol.\u003c\/li\u003e\n\u003cli\u003eSide effects of both individual compounds may apply — see BPC-157 and TB-500 descriptions.\u003c\/li\u003e\n\u003cli\u003eCombination human safety data is very limited.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498585240,"sku":"BL-WOLVERINE-BLEND-BPC-157-TB-500","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/BPC_TB500.png?v=1777263944"},{"product_id":"cjc-1295-ipamorelin","title":"CJC-1295 \/ Ipamorelin","description":"\u003cp\u003e\u003cstrong\u003eGrowth hormone secretagogue combination supporting GH pulsatility.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eCJC-1295 is a synthetic GHRH analog. Ipamorelin is a synthetic GHRP acting as a ghrelin receptor agonist. Together they stimulate pituitary GH release through two complementary pathways. Both are compounded peptides, not FDA-approved medications. This combination is assessed in the context of a full hormone panel.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eCJC-1295 prolongs GHRH activity. Ipamorelin stimulates GH release via the ghrelin receptor without significantly affecting cortisol or prolactin at standard doses. Clinical outcome depends on baseline GH axis function and is individual.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eAssessed as part of a full hormone panel — not prescribed as a standalone.\u003c\/li\u003e\n\u003cli\u003eCommonly reported: improved sleep quality, water retention, tingling in extremities early in use.\u003c\/li\u003e\n\u003cli\u003eRequires IGF-1 and hormone panel review.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eWater retention, particularly in the first 2–4 weeks — common with GH optimization protocols.\u003c\/li\u003e\n\u003cli\u003eTingling or numbness in the extremities (carpal tunnel-like sensation) — typically resolves with dose adjustment.\u003c\/li\u003e\n\u003cli\u003eMild headache or flushing immediately following injection.\u003c\/li\u003e\n\u003cli\u003ePotential for blood glucose changes — discuss monitoring with your provider if metabolic conditions are present.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498650776,"sku":"BL-CJC-1295-IPAMORELIN","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/Cjc_ipa.png?v=1777263944"},{"product_id":"sermorelin","title":"Sermorelin","description":"\u003cp\u003e\u003cstrong\u003eGHRH analog with a longer clinical history than newer secretagogues.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eSermorelin is a synthetic analog of the first 29 amino acids of endogenous GHRH. It has a longer clinical history than CJC-1295. It stimulates physiological GH release through the pituitary. As a compounded peptide, it is not FDA-approved in its current formulation.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eActs on GHRH receptors in the pituitary to stimulate GH secretion. More conservative mechanism than GHRP combinations. Preferred when a gentler entry into GH optimization is appropriate.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eAssessed in the context of a hormone panel.\u003c\/li\u003e\n\u003cli\u003eEstablished safety profile relative to newer secretagogues.\u003c\/li\u003e\n\u003cli\u003eRequires provider evaluation.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site redness or discomfort.\u003c\/li\u003e\n\u003cli\u003eMild flushing or warmth shortly after injection.\u003c\/li\u003e\n\u003cli\u003eHeadache reported by some users early in the protocol.\u003c\/li\u003e\n\u003cli\u003eWater retention and tingling are less commonly reported with Sermorelin than with CJC-1295\/Ipamorelin combinations.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498716312,"sku":"BL-SERMORELIN","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/Sermorelin.png?v=1777263944"},{"product_id":"glutathione-injection","title":"Glutathione Injection","description":"\u003cp\u003e\u003cstrong\u003eSystemic glutathione replenishment via subcutaneous injection.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eGlutathione is a tripeptide functioning as the body's primary endogenous antioxidant. Levels decline with age, chronic illness, and oxidative stress. Oral glutathione has poor bioavailability due to GI degradation. SubQ injection delivers glutathione systemically. This is a supportive compound, not a treatment for any specific condition.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eGlutathione neutralizes reactive oxygen species, supports liver Phase II detoxification, and plays a role in immune regulation. The brain has among the highest tissue concentrations of glutathione.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eConsistent use over weeks to months is required to assess response.\u003c\/li\u003e\n\u003cli\u003eSkin-clarifying effects have been observationally reported with consistent use — this is a side effect, not a primary clinical indication.\u003c\/li\u003e\n\u003cli\u003eNot a treatment for liver disease, immune disorders, or skin conditions.\u003c\/li\u003e\n\u003cli\u003eIndividual response varies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eInjection site discomfort or mild bruising.\u003c\/li\u003e\n\u003cli\u003eRare reports of mild skin lightening with consistent high-dose use — a side effect, not an intended indication.\u003c\/li\u003e\n\u003cli\u003eNo serious adverse events prominently reported at standard clinical doses in available literature.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498814616,"sku":"BL-GLUTATHIONE-INJECTION","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/Glutathione_compounded_solution_in_vial.png?v=1777263943"},{"product_id":"glow-blend","title":"Glow Blend","description":"\u003cp\u003e\u003cstrong\u003eProvider-formulated combination protocol — formulation set at consultation.\u003c\/strong\u003e\u003c\/p\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cp\u003eThe Glow Blend is a provider-formulated combination protocol. The specific formulation is determined at consultation based on individual goals and provider assessment. It is not a standardized product.\u003c\/p\u003e\u003ch3\u003eMechanism\u003c\/h3\u003e\u003cp\u003eComposition varies. Anti-inflammatory and tissue repair-signaling properties of the component peptides are the basis for both skin health and recovery applications.\u003c\/p\u003e\u003ch3\u003eClinical Considerations\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eFormulation is determined at consultation. Not a standardized product.\u003c\/li\u003e\n\u003cli\u003eIndividual response depends on formulation, consistency of use, and individual biology.\u003c\/li\u003e\n\u003cli\u003eRequires provider evaluation.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003ePotential Side Effects\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eSide effects depend on the specific formulation determined at consultation.\u003c\/li\u003e\n\u003cli\u003eInjection site reactions standard for any SubQ protocol.\u003c\/li\u003e\n\u003cli\u003eYour provider will review the side effect profile of each component at time of prescription.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eAll prescriptions require a telehealth consultation with a licensed provider. A prescription is not guaranteed. Individual results vary. Not FDA-approved unless noted otherwise.\u003c\/em\u003e\u003c\/p\u003e","brand":"Baseline","offers":[{"title":"Default Title","offer_id":48933498912920,"sku":"BL-GLOW-BLEND","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/files\/Glow_Blend.png?v=1777263943"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0756\/4656\/6552\/collections\/GLPs.png?v=1777265619","url":"https:\/\/improvedbaseline.com\/collections\/treatments.oembed","provider":"Baseline","version":"1.0","type":"link"}